Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Other Non-Current Assets (2022 - 2025)

Cingulate's (CINGW) quarterly Other Non-Current Assets came in at $59383.0 in Q4 2025, up 331.47% quarter-over-quarter from $13763.0 in Q3 2024.

Analysis

Cingulate (CINGW) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Other Non-Current Assets for 4 consecutive years, with $59383.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets changed N/A year-over-year to $59383.0; the trailing twelve-month figure through Dec 2025 stood at $59383.0 (changed N/A YoY), and the FY2025 full-year result was $59383.0, changed N/A from the prior year.
  • Other Non-Current Assets rose to $59383.0 in Q4 2025 per CINGW's latest filing, from $13763.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $178780.0 in Q4 2023 and bottomed at $13763.0 in Q3 2024.
  • Historically, Other Non-Current Assets has averaged $84342.8 across 4 years, with a median of $69449.0 in 2024.
  • The widest YoY moves for Other Non-Current Assets: up 78.18% in 2023, down 78.18% in 2023.
  • Over 4 years, Other Non-Current Assets stood at $100339.0 in 2022, then soared by 78.18% to $178780.0 in 2023, then tumbled by 92.3% to $13763.0 in 2024, then jumped by 331.47% to $59383.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $59383.0, $13763.0, and $69449.0 for Q4 2025, Q3 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 14.27 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 10.73 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 5.93 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 42.45 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 239.50 Mn
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 59,383.00
Sep 30, 2024 13,763.00
Jun 30, 2024 69,449.00
Dec 31, 2023 178,780.00
Dec 31, 2022 100,339.00